Viewing Study NCT00017758

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 12:12 AM
Ignite Modification Date: 2025-12-25 @ 10:14 PM
Study NCT ID: NCT00017758
Status: COMPLETED
Last Update Posted: 2006-03-14
First Post: 2001-06-11
Is NOT Gene Therapy: False
Has Adverse Events: False
Brief Title: The Effect of Efavirenz and Nelfinavir on the Blood Levels of Certain Lipid-Lowering Drugs
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None HIV Infections View
None HIV Seronegativity View
None Lipodystrophy View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Drug Interactions View
None Nelfinavir View
None Reverse Transcriptase Inhibitors View
None Anti-HIV Agents View
None Pharmacokinetics View
None Pravastatin View
None efavirenz View
None Simvastatin View
None atorvastatin View
None Hydroxymethylglutaryl-CoA Reductase Inhibitors View